RU72137U1 - DEVICE FOR INFUSION OF OZONIZED PHYSIOLOGICAL SOLUTION - Google Patents

Abstract

Device for infusion of ozonized physiological solution, consisting of the arterial part of the blood supply line for dialysis and a roller regulator, characterized in that the device contains an air trap that operates without contact of the ozonized physiological solution with air, with a predominantly laminar fluid flow, located in the line after the bottle with ozonized saline solution, as well as a precision roller regulator containing a discrete and calibrated speed scale in diffusion system and located downstream of the air trap.

Description

The utility model relates to medicine, namely to physiotherapy, extracorporeal detoxification.

Intravenous drip of ozonized physiological saline (OGF) is a simple and effective parenteral route. It allows the most efficient use of the powerful catalytic, oxidizing properties of ozone. Infusion of ozonized saline is carried out from standard vials of various volumes intravenously [1,2].

A device is known - [3] a system for transfusion of infusion solutions with a plastic spike, consisting of:

- a plastic needle for a bottle,

- needle capacity,

- nylon microfilter,

- roller adjuster,

- transparent connecting tubes,

- rubber injection unit,

- Luer compounds,

- injection needle with atraumatic sharpening.

The principle of operation of the system for transfusion is based on the drip gravitational introduction of OFR through a series of elements described above directly into the blood, the infusion rate is regulated by a roller regulator. However, the use of this device during intravenous infusion of FGF leads to significant losses of ozone, especially in the needle-holding capacity (up to 60%), and also does not allow accurate dosage of the infusion rate [4,5]. Given the clear dose-dependent nature of the ozone therapeutic effect, there is an objective need to reduce the infusion loss of ozone from the OGF, as well as to ensure clear control over the rate of infusion [6,7].

The purpose of the utility model is to reduce ozone losses, as well as maintaining a stable infusion rate of ozonized saline.

This goal is achieved by the presence in the device of an air trap from the arterial part of the universal dialysis blood supply line (manufacturer Fresenius, model FA204C), as well as a precision regulator of the rate of injection of solutions (manufacturer Bbraun, model Exadrop). The arrangement of the elements of the device is as follows: after the vial with OGF, there follows an arterial dialysis line with an air trap, which differs from the needle tank in that the contact of the solution with air is minimized, the solution is infused directly into the filled part of the trap container, and the fluid flow is as close as possible to the laminar type . The line is connected to a precision roller speed controller, allowing more precisely

in comparison with the roller regulator, to dose the injected solutions, due to the presence on it of a discrete and calibrated scale of the infusion rate. A precision regulator is followed by a Luer type connection.

The proposed device (Fig.) Is the arterial part of the circulatory dialysis line (1) with an air trap (2) hermetically connected to a precision regulator of the rate of introduction of solutions (3). The assembly of the device is carried out according to the principles of asepsis immediately before the start of the infusion of FGM. The infusion system assembled in this way is filled from the vial with OPF before use. Through a rubber stopper a disposable needle is inserted into the bottle - an air graduate.

The device operates as follows. The filled system is connected to a venipuncture needle or catheter. Carry out venous access. Next, set the desired infusion rate on a precision roller regulator. At the end of the infusion, the system is sanitized.

During the infusion, we monitored the ozone content in the vial and at the exit from the infusion systems. The analysis of the obtained results, in comparison with the standard system for infusion, showed a significant decrease in the ozone losses in our device by an average of 43.3%. Ozone was measured spectrophotometrically at the medical ozone therapy unit UOTA-60-01 "MEDOZON" with a microprocessor control system, as well as iodometrically according to the generally accepted method.

Using the device leads to a significant reduction in the amount of FGF infusion as part of a course of ozone therapy, reducing the duration of the above procedures, reducing the number of iatrogenic complications, as well as the cost of treatment.

Information sources:

1. Boyarinov G.A., Sokolov V.V. Theoretical background for the use of ozone and gutimin to increase the effectiveness of cardiopulmonary bypass. Monograph "Ozonated cardiopulmonary bypass". - N. Novgorod. - 1999. - P.5-6.

2. Maslennikov OV, Andosov SV, Gribkova I.A., Eremina L.N. Ozone therapy for internal diseases // Materials of the IV All-Russian Scientific and Practical Conference "Ozone and Methods of Efferent Therapy in Medicine". - N. Novgorod, 2000 .-- S. 43-44.

3. Morozov M.A. Surgery: A Handbook for a Nurse. - Publishing House Peter. - 2000. - P.352.

4. Nazarov E.I. Some causes of ozone dosage errors with intravenous administration of FGM and methods for overcoming them // Materials of the First Ukrainian-Russian Scientific and Practical Conference “Ozone in Biology and Medicine”. - Simferopol, 2003. - S.7-8.

5. Razumovsky S. D. The stability of ozone and ozonides in solutions and ways to increase it // Materials of the IV All-Russian scientific-practical conference "Ozone and methods of efferent therapy in medicine". - KNovgorod, 2000. - S.11-12.

6. Kontorschikova K.N., Efremenko Yu.R., Okrut I.E. Dose-dependent effect of ozone on the proteolytic systems of the body // Materials of the IV All-Russian Scientific and Practical Conference "Ozone and Methods of Efferent Therapy in Medicine". - N. Novgorod, 2000 .-- S.53-54.

7. Shcherbatyuk T.G., Moskovtseva O.M., Sedunova N.V., Lyapina O.V., Pleskova A.N., Pyavkina A.A., Markov S.V. Dose-dependent effect of ozonized saline on some indicators of homeostasis of animal tumor carriers in vitro and in vivo // Materials of the IV All-Russian Scientific and Practical Conference “Ozone and Methods of Efferent Therapy in Medicine”. - N. Novgorod, 2000 .-- S.25-28.

Claims (1)

Device for infusion of ozonized physiological solution, consisting of the arterial part of the blood supply line for dialysis and a roller regulator, characterized in that the device contains an air trap that operates without contact of the ozonized physiological solution with air, with a predominantly laminar fluid flow, located in the line after the bottle with ozonized saline solution, as well as a precision roller controller containing a discrete and calibrated speed scale in diffusion system and located downstream of the air trap.